Quantifying the risk-reduction potential of new Modified Risk Tobacco Products

scientific article published on 16 December 2017

Quantifying the risk-reduction potential of new Modified Risk Tobacco Products is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.YRTPH.2017.12.011
P698PubMed publication ID29258927

P2093author name stringFlorian Martin
Rolf Weitkunat
Gregory Vuillaume
Paolo F Ricci
Frank Lüdicke
Gizelle Baker
Zheng Sponsiello-Wang
P2860cites workSystematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysemaQ21093297
Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancerQ28391315
Reduced Exposure to Harmful and Potentially Harmful Smoke Constituents With the Tobacco Heating System 2.1.Q37585216
Using the negative exponential distribution to quantitatively review the evidence on how rapidly the excess risk of ischaemic heart disease declines following quitting smoking.Q38021290
How rapidly does the excess risk of lung cancer decline following quitting smoking? A quantitative review using the negative exponential model.Q38114247
Estimating the decline in excess risk of cerebrovascular disease following quitting smoking--a systematic review based on the negative exponential model.Q38167559
Estimating the decline in excess risk of chronic obstructive pulmonary disease following quitting smoking - a systematic review based on the negative exponential model.Q38173172
Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment programQ38906325
A novel approach to assess the population health impact of introducing a Modified Risk Tobacco Product.Q41144706
Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smokingQ45221728
Evaluation of the Tobacco Heating System 2.2. Part 8: 5-Day randomized reduced exposure clinical study in PolandQ50277300
Estimating the effect of differing assumptions on the population health impact of introducing a Reduced Risk Tobacco Product in the USA.Q50560026
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 6: 6-Day randomized clinical trial of a menthol cigarette in Japan.Q51312965
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 4: Eight-day randomized clinical trial in Korea.Q51312968
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 5: 8-Day randomized clinical trial in Japan.Q51313800
Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 3: Eight-day randomized clinical trial in the UK.Q51313803
Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system.Q51759214
Assessment of the reduction in levels of exposure to harmful and potentially harmful constituents in Japanese subjects using a novel tobacco heating system compared with conventional cigarettes and smoking abstinence: A randomized controlled study iQ53559897
P407language of work or nameEnglishQ1860
P304page(s)358-369
P577publication date2017-12-16
P1433published inRegulatory Toxicology and PharmacologyQ2138805
P1476titleQuantifying the risk-reduction potential of new Modified Risk Tobacco Products
P478volume92

Reverse relations

cites work (P2860)
Q58118984Estimating the population health impact of introducing a reduced-risk tobacco product into Japan. The effect of differing assumptions, and some comparisons with the U.S
Q55514553Modeling the Population Health Impact of Introducing a Modified Risk Tobacco Product into the U.S. Market.
Q49346082Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products

Search more.